To summarize the results of a cross-sectional epidemiologic study of Japanese office workers who use visual display terminals (VDTs).
Workers in a pharmaceutical company head office were recruited. Participants were requested to complete a questionnaire on symptoms of dry eye disease (DED) and evaluations using the Work Limitations Questionnaire, International Physical Activity Questionnaire, Subjective Happiness Scale, and Pittsburgh Sleep Quality Index. Evaluations of ocular status, including conjunctival and corneal vital staining with lissamine green and fluorescein, measurement of tear film breakup time, and the Schirmer test, were performed. The Japanese 2007 diagnostic criteria for DED were implemented.
The prevalence of DED among VDT workers was high. Definite DED was present in 11.6% (18.7% women and 8.0% men) of participants, and probable DED was present in 54.0% (57.8% women and 52.1% men). Total loss of workplace productivity was significantly greater in the definite DED group (4.82%) than in the probable DED group (4.06%) and the non-DED group (3.56%, P < 0.014, trend test). Participants with definite DED had significantly lower physical activity scores than those without DED (P = 0.025). Subjective happiness correlated with the dry eye symptom score (r = −0.188; P < 0.001). Participants with DED reported poor sleep quality at a higher rate compared with those without DED (45% vs. 34%), with a significant difference in the global score (P = 0.002).
Dry eye is prevalent among VDT workers. Its impacts on work productivity, physical activity, and sleep quality warrant further study.
*Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan; and
†Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Correspondence: Miki Uchino, MD, MPH, PhD, Department of Ophthalmology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan (e-mail: firstname.lastname@example.org).
N. Yokoi is a consultant for Kissei Co, Ltd, and Rohto Co, Ltd. K. Tsubota has received consultant fees and research funding from Santen Pharmaceutical Co, Ltd, and Kowa Company. This study was a collaborative investigation by the Dry Eye Society (Tokyo, Japan) and Santen Pharmaceutical Co, Ltd (Osaka, Japan). Santen Pharmaceutical Co, Ltd, provided the research facilities and assisted in the transport of equipment. The remaining authors have no funding or conflicts of interest to disclose.
Presented at the 23rd Kyoto Cornea Club Meeting, held on 24 and 25 November 2017 in Kyoto, Japan.
Received June 28, 2018
Received in revised form July 09, 2018
Accepted July 13, 2018